Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 113

1.

Familial pulmonary arterial hypertension at a tertiary referral unit: patterns in presentation and prognosis.

Esmaili A, Jary C, Bulsara M, Fear M, Gabbay E.

Intern Med J. 2015 Mar;45(3):362-3. doi: 10.1111/imj.12695. No abstract available.

PMID:
25735585
2.

A comparison of the predictive accuracy of three screening models for pulmonary arterial hypertension in systemic sclerosis.

Hao Y, Thakkar V, Stevens W, Morrisroe K, Prior D, Rabusa C, Youssef P, Gabbay E, Roddy J, Walker J, Zochling J, Sahhar J, Nash P, Lester S, Rischmueller M, Proudman SM, Nikpour M.

Arthritis Res Ther. 2015 Jan 18;17(1):7. doi: 10.1186/s13075-015-0517-5.

3.

Incentives for caution: the in-center hemodialysis consumer assessment of healthcare providers and systems survey and experience of care.

Gabbay E, Meyer KB.

Clin J Am Soc Nephrol. 2014 Jun 6;9(6):1005-6. doi: 10.2215/CJN.03950414. Epub 2014 May 15. No abstract available.

PMID:
24832094
4.

The association of antiphospholipid antibodies with cardiopulmonary manifestations of systemic sclerosis.

Morrisroe KB, Stevens W, Nandurkar H, Prior D, Thakkar V, Roddy J, Zochling J, Sahhar J, Tymms K, Sturgess A, Major G, Kermeen F, Hill C, Walker J, Nash P, Gabbay E, Youssef P, Proudman SM, Nikpour M.

Clin Exp Rheumatol. 2014 Nov-Dec;32(6 Suppl 86):S-133-7. Epub 2014 Feb 24.

PMID:
24564981
5.

The inclusion of N-terminal pro-brain natriuretic peptide in a sensitive screening strategy for systemic sclerosis-related pulmonary arterial hypertension: a cohort study.

Thakkar V, Stevens W, Prior D, Youssef P, Liew D, Gabbay E, Roddy J, Walker JG, Zochling J, Sahhar J, Nash P, Lester S, Rischmueller M, Proudman SM, Nikpour M.

Arthritis Res Ther. 2013;15(6):R193.

6.

Psychometric performance of the CAMPHOR and SF-36 in pulmonary hypertension.

Twiss J, McKenna S, Ganderton L, Jenkins S, Ben-L'amri M, Gain K, Fowler R, Gabbay E.

BMC Pulm Med. 2013 Jul 12;13:45. doi: 10.1186/1471-2466-13-45.

7.

Should patients with systemic sclerosis-related pulmonary arterial hypertension be anticoagulated?

Nikpour M, Stevens W, Proudman SM, Buchbinder R, Prior D, Zochling J, Williams T, Gabbay E, Nandurkar H.

Intern Med J. 2013 May;43(5):599-603. doi: 10.1111/imj.12111. Review.

PMID:
23668273
8.

Time from symptoms to definitive diagnosis of idiopathic pulmonary arterial hypertension: The delay study.

Strange G, Gabbay E, Kermeen F, Williams T, Carrington M, Stewart S, Keogh A.

Pulm Circ. 2013 Jan;3(1):89-94. doi: 10.4103/2045-8932.109919.

9.

Chronic thromboembolic pulmonary hypertension: treat the patient not the haemodynamics.

Dunne B, van den Broek A, Williams V, Smith G, Revesz T, Edwards M, Gabbay E.

Case Rep Pulmonol. 2012;2012:108672. doi: 10.1155/2012/108672. Epub 2012 Oct 22.

10.

Increase in the proportion of patients hospitalized with acute myocardial infarction with do-not-resuscitate orders already in place between 2001 and 2007: a nonconcurrent prospective study.

Saczynski JS, Gabbay E, McManus DD, McManus R, Gore JM, Gurwitz JH, Lessard D, Goldberg RJ.

Clin Epidemiol. 2012;4:267-74. doi: 10.2147/CLEP.S32034. Epub 2012 Oct 19.

11.

Design and delivery of an e-learning curriculum for physicians involved in the management of pulmonary hypertension.

Dalton B, McNeil K, Keogh A, Williams T, Proudman S, Gabbay E, Kotlyar E, Weintraub R, Kermeen F, Celermajer D, Boland J.

Int J Clin Pract. 2012 Nov;66(11):1117-24. doi: 10.1111/j.1742-1241.2012.02997.x.

PMID:
23067036
12.

Extent of disease on high-resolution computed tomography lung is a predictor of decline and mortality in systemic sclerosis-related interstitial lung disease.

Moore OA, Goh N, Corte T, Rouse H, Hennessy O, Thakkar V, Byron J, Sahhar J, Roddy J, Gabbay E, Youssef P, Nash P, Zochling J, Proudman SM, Stevens W, Nikpour M.

Rheumatology (Oxford). 2013 Jan;52(1):155-60. doi: 10.1093/rheumatology/kes289. Epub 2012 Oct 13.

13.

Predictors of mortality in connective tissue disease-associated pulmonary arterial hypertension: a cohort study.

Ngian GS, Stevens W, Prior D, Gabbay E, Roddy J, Tran A, Minson R, Hill C, Chow K, Sahhar J, Proudman S, Nikpour M.

Arthritis Res Ther. 2012 Oct 5;14(5):R213. doi: 10.1186/ar4051.

14.

Pulmonary hypertension: prevalence and mortality in the Armadale echocardiography cohort.

Strange G, Playford D, Stewart S, Deague JA, Nelson H, Kent A, Gabbay E.

Heart. 2012 Dec;98(24):1805-11. doi: 10.1136/heartjnl-2012-301992. Epub 2012 Jul 3.

15.

Exercise intolerance in pulmonary arterial hypertension.

Fowler RM, Gain KR, Gabbay E.

Pulm Med. 2012;2012:359204. doi: 10.1155/2012/359204. Epub 2012 Jun 10.

16.

Kidney failure treatment: the freedom to choose.

Gabbay E, Meyer KB.

Am J Kidney Dis. 2012 Jul;60(1):5-7. doi: 10.1053/j.ajkd.2012.04.005. No abstract available.

PMID:
22709596
17.

N-terminal pro-brain natriuretic peptide in a novel screening algorithm for pulmonary arterial hypertension in systemic sclerosis: a case-control study.

Thakkar V, Stevens WM, Prior D, Moore OA, Byron J, Liew D, Patterson K, Hissaria P, Roddy J, Zochling J, Sahhar J, Nash P, Tymms K, Celermajer D, Gabbay E, Youssef P, Proudman SM, Nikpour M.

Arthritis Res Ther. 2012 Jun 12;14(3):R143. doi: 10.1186/ar3876.

18.

Prognostic models for older adults.

Gabbay E, Kent DM.

JAMA. 2012 May 9;307(18):1911-2; author reply 1912. doi: 10.1001/jama.2012.3568. No abstract available.

PMID:
22570454
19.

A comparison of the acute haemodynamic response to aerobic and resistance exercise in subjects with exercise-induced pulmonary arterial hypertension.

Fowler RM, Maiorana AJ, Jenkins SC, Gain KR, O'Driscoll G, Gabbay E.

Eur J Prev Cardiol. 2013 Aug;20(4):605-12. doi: 10.1177/2047487312445424. Epub 2012 Apr 13.

PMID:
22505056
20.

Australian perspective regarding recommendations for physical activity and exercise rehabilitation in pulmonary arterial hypertension.

Fowler R, Jenkins S, Maiorana A, Gain K, O'Driscoll G, Gabbay E.

J Multidiscip Healthc. 2011;4:451-62. doi: 10.2147/JMDH.S26617. Epub 2011 Dec 20.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk